INMED PHARMACEUTICALS INC. Class of Warrant or Right, Outstanding
INMED PHARMACEUTICALS INC. (INM) had Class of Warrant or Right, Outstanding of 694.02 thousand shares as of 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2024-09-30
- 2024-06-30: Class of Warrant or Right, Outstanding 694.02K shares.
- 2023-12-31: Class of Warrant or Right, Outstanding 700.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2024-06-30 | 694.02K shares 10-K · filed 2024-09-30 |
| 2023-12-31 | 700.00 shares 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |